In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

The US Centers for Disease Control and Prevention (CDC) in its weekly update today reported 42 measles cases, some tied to a ...

Surveillance identified 7,381 candidemia cases, with an incidence of 7.4 cases per 100,000 people. Across age-groups, sexes, ...

The 19 low- and middle-income countries experienced 28,000 congenital rubella syndrome cases—78% of the world's cases—in 2023 ...

The data show a continuation of a decades-old trend toward increasing US excess deaths, mainly among working-age adults, ...

Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

Cambodia's ministry of health has reported its fourth fatal human H5N1 avian flu case of the year, which involves an ...

The CDC is still recommending COVID vaccination for children ages 6 months to 17 years who are moderately or severely ...

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

A large observational study provides evidence that antibiotics provide no benefit for patients hospitalized with nonsevere ...

Long-COVID symptoms were based on caregiver-reported symptoms lasting at least 90 days after COVID infections; in total 41 ...